Gary Baker
1 Papers
2 Citations
Gary Baker is an academic researcher. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Pharmaceutical development of IPI-504, an Hsp90 inhibitor and clinical candidate for the treatment of cancer
James R. Porter,Julian Adams,Rebecca Ahn,Vince Ammoscato,Brendan Arsenault,Brian C. Austad,Gary Baker,Johan Sebastian Basuki,Marlene R. Booth,Matthew Campbell,Bennett Carter,Michael Curtis,Kris Depew,Mark Douglas,Jie Ge,Louis Grenier,Joseph Helble,John Henderson,Natalie Goltz,Dumitru Ionescu,Laila Kott,Jason Kropp,John Lee,Kaiming Li,Bradley Maurer,Denise Mayes,Roger H. Pak,Jason J. Piotrowski,Jennifer R. Porter,David Rusch,Geoff E. Sylvester,Steven G. Wong,James R. Wright +32 more
TL;DR: The development challenges associated with redox active molecules are significant due to the pH, oxygen, and temperature sensitivities associated with such chemotypes and the API and sterile drug product manufacturing processes thus warrant the monitoring and control of these key variables.
2